Pancreatic Ductal Adenocarcinoma — Trials

Pancreatic Ductal Adenocarcinoma — Trials · CancerIndex

Clinical trials

Registered studies

414 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 208
Recruiting: 129
Ph III recruiting: 13
Growth YoY: +56.5%
Industry share: 50%
Top sponsor: Revolution Medicines, Inc.
Termination share: 46.8%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (56)

clinicaltrialsPublishedShowing 1–3 of 3 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT05634720	Hepatic Artery Chemotherapy for Patients With Localized Pancreas Cancer	active not recruiting	Phase 4	20	Duke UniversityOTHER	1	Jan 26, 2026	clinicaltrials
NCT06077487	Ketamine-assisted Therapy for Advanced GI Cancer	terminated	Phase 4	1	Brian Anderson, MDOTHER	1	May 21, 2025	clinicaltrials
NCT02570529